Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for O95772

Entry ID Method Resolution Chain Position Source
AF-O95772-F1 Predicted AlphaFoldDB

164 variants for O95772

Variant ID(s) Position Change Description Diseaes Association Provenance
rs766409769
CA4223356
5 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA4223357
rs776780254
7 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs1212324312
CA367223739
7 D>H No ClinGen
gnomAD
rs776780254
CA367223742
7 D>V No ClinGen
ExAC
TOPMed
gnomAD
rs759554337
CA4223358
8 M>L No ClinGen
ExAC
gnomAD
CA367223748
rs1212748757
8 M>T No ClinGen
TOPMed
gnomAD
rs759554337
CA367223746
8 M>V No ClinGen
ExAC
gnomAD
rs752557250
CA367223770
11 A>S No ClinGen
ExAC
TOPMed
gnomAD
rs752557250
CA4223360
11 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1247822475
CA367223774
12 L>F No ClinGen
gnomAD
CA367223785
rs1475102061
13 T>I No ClinGen
gnomAD
CA367223784
rs1475102061
13 T>S No ClinGen
gnomAD
CA4223363
rs139771990
CA4223364
14 G>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA367223789
rs1478262467
14 G>V No ClinGen
gnomAD
CA4223365
rs780533970
15 S>G No ClinGen
ExAC
gnomAD
CA157165478
rs376203945
16 Q>R No ClinGen
ESP
TOPMed
gnomAD
CA367223809
rs1324082644
17 S>I No ClinGen
TOPMed
gnomAD
CA367223804
rs1406901141
17 S>R No ClinGen
gnomAD
rs1014661155
CA157165479
17 S>R No ClinGen
Ensembl
rs11547101
CA367223814
18 S>C No ClinGen
gnomAD
CA367223811
rs1307099525
18 S>T No ClinGen
TOPMed
rs11547101
CA157165480
18 S>Y No ClinGen
gnomAD
rs779108893
CA4223368
19 H>P No ClinGen
ExAC
gnomAD
CA4223370
rs772162881
19 H>Q No ClinGen
ExAC
gnomAD
rs779108893
CA4223369
19 H>R No ClinGen
ExAC
gnomAD
rs755503425
CA4223367
19 H>Y No ClinGen
ExAC
gnomAD
rs778119963
CA4223371
20 A>P No ClinGen
ExAC
gnomAD
CA4223372
rs749040997
23 R>C Variant assessed as Somatic; 4.62e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA367223838
rs1230414650
23 R>H No ClinGen
TOPMed
gnomAD
CA367223855
rs1409422555
25 I>M No ClinGen
TOPMed
gnomAD
CA367223856
rs1291085966
26 H>N No ClinGen
gnomAD
CA367223860
rs1329679255
26 H>R No ClinGen
TOPMed
gnomAD
rs144473137
CA4223373
27 S>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs144473137
CA4223374
27 S>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA367223875
rs1214348408
29 N>H No ClinGen
gnomAD
CA367223880
rs1455554387
29 N>I No ClinGen
TOPMed
CA367223886
rs1265419960
30 P>H No ClinGen
gnomAD
CA4223375
rs145400559
31 T>A No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA157165561
rs1047102746
32 Q>R No ClinGen
TOPMed
rs1415998182
CA367223905
33 L>R No ClinGen
TOPMed
gnomAD
CA367223915
rs1473921192
34 M>I No ClinGen
TOPMed
gnomAD
CA367223911
rs1417888575
34 M>T Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1163603776
CA367223920
35 A>V No ClinGen
gnomAD
CA367223924
rs1407059177
36 R>K No ClinGen
TOPMed
gnomAD
CA367223925
rs1407059177
36 R>T No ClinGen
TOPMed
gnomAD
CA157165583
rs969669344
38 E>D No ClinGen
Ensembl
CA367223953
rs1384002976
40 Y>C No ClinGen
TOPMed
gnomAD
CA367223962
rs1360538408
41 E>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs775112688
CA4223377
42 G>R No ClinGen
ExAC
gnomAD
CA367223972
rs1286234851
43 R>K No ClinGen
TOPMed
CA367223986
rs1247652982
45 K>E No ClinGen
gnomAD
TCGA novel 45 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1215281486
CA367223988
45 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA367223995
rs1310652315
46 K>E No ClinGen
gnomAD
CA367224004
rs1350828875
47 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA367224009
rs1294676347
48 I>V No ClinGen
TOPMed
CA4223378
rs762851533
51 V>I No ClinGen
ExAC
gnomAD
CA367224040
rs1285139225
53 R>G No ClinGen
gnomAD
TCGA novel 53 R>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770608944
CA157165594
53 R>T No ClinGen
Ensembl
CA367224073
rs1340335580
57 L>F No ClinGen
TOPMed
CA367224080
rs1311039414
58 F>S No ClinGen
TOPMed
CA367224094
rs1294985342
60 T>I No ClinGen
gnomAD
rs766953026
CA4223382
64 L>V No ClinGen
ExAC
gnomAD
CA367224124
rs1362947548
65 F>L No ClinGen
TOPMed
rs996270147
CA157165624
66 V>I No ClinGen
TOPMed
gnomAD
rs1254231114
CA367224175
72 I>M No ClinGen
gnomAD
CA157165629
rs1032363189
72 I>T No ClinGen
Ensembl
CA4223386
rs752990456
74 L>I No ClinGen
ExAC
gnomAD
CA367224184
rs752990456
74 L>V No ClinGen
ExAC
gnomAD
TCGA novel 76 V>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA157170121
rs1040080762
81 E>Q No ClinGen
TOPMed
gnomAD
rs769592313
CA4223394
83 T>I No ClinGen
ExAC
gnomAD
CA367224274
rs1191739969
85 E>G No ClinGen
gnomAD
rs1290154704
CA367224288
87 E>K No ClinGen
TOPMed
CA4223396
rs762651219
88 V>L No ClinGen
ExAC
gnomAD
rs1393836049
CA367224305
89 M>I No ClinGen
gnomAD
CA367224320
rs1333776216
91 Y>C No ClinGen
gnomAD
rs1224206798
CA367224326
92 D>N No ClinGen
TOPMed
CA367224344
rs1401568173
94 Y>C No ClinGen
gnomAD
rs774143220
CA4223398
95 S>Y No ClinGen
ExAC
gnomAD
rs767198270
CA4223400
COSM187172
99 D>G Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs767198270
CA157170147
COSM1089468
99 D>V Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1332852861
CA367224377
99 D>Y No ClinGen
gnomAD
CA367224382
rs1562618795
100 I>V No ClinGen
Ensembl
CA4223423
rs267601506
107 R>* No ClinGen
ESP
ExAC
gnomAD
rs760254369
CA367224440
107 R>L No ClinGen
ExAC
gnomAD
CA4223424
rs760254369
COSM1622826
107 R>Q Variant assessed as Somatic; 0.0 impact. liver [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs1183764237
CA367224493
115 Y>C No ClinGen
TOPMed
rs940455413
CA157170659
117 V>L No ClinGen
gnomAD
CA367224516
rs1370617065
119 R>G No ClinGen
gnomAD
rs757750374
CA4223430
119 R>I No ClinGen
ExAC
TOPMed
gnomAD
rs767844751
CA4223431
121 R>C No ClinGen
ExAC
gnomAD
rs750591308
CA4223432
121 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA367224535
rs1197878469
122 H>R No ClinGen
Ensembl
rs1351985970
CA367224541
123 W>G No ClinGen
TOPMed
CA367224565
rs1237314416
126 I>K No ClinGen
TOPMed
rs574853669
CA4223434
126 I>V No ClinGen
ExAC
gnomAD
COSM746972
CA4223435
rs749369688
127 A>V lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs778969449
CA4223454
COSM1450602
130 T>A large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA4223455
rs752576439
COSM76609
130 T>M ovary large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA157172247
rs767014652
132 V>G No ClinGen
Ensembl
CA367224608
rs1562620977
132 V>M No ClinGen
Ensembl
CA367224620
rs1483759753
134 S>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA157172255
rs1005342343
135 A>T No ClinGen
TOPMed
CA367224666
rs1198386242
141 V>M No ClinGen
gnomAD
CA367224675
rs1188895987
142 I>N No ClinGen
TOPMed
TCGA novel 143 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1339281795
CA367224724
147 F>L No ClinGen
gnomAD
rs1268225237
CA367224720
147 F>Y No ClinGen
TOPMed
rs757062566
CA4223477
148 S>C No ClinGen
ExAC
gnomAD
rs781042419
CA4223478
149 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA367224745
rs1243866763
151 A>P No ClinGen
TOPMed
gnomAD
CA4223479
rs745458803
158 I>V No ClinGen
ExAC
gnomAD
CA367224800
rs1271220960
159 I>T No ClinGen
TOPMed
rs779669492
CA4223481
162 I>V No ClinGen
ExAC
gnomAD
rs564690290
CA4223482
168 T>M No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 169 W>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4223484
rs773660378
175 V>M No ClinGen
ExAC
gnomAD
rs761249192
CA4223485
177 P>L No ClinGen
ExAC
gnomAD
CA4223486
rs771143236
178 Q>K No ClinGen
ExAC
TOPMed
gnomAD
CA4223487
rs777006591
179 E>G No ClinGen
ExAC
gnomAD
TCGA novel 180 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1165415606
CA367224950
181 E>A No ClinGen
gnomAD
CA367224951
rs1165415606
181 E>G No ClinGen
gnomAD
rs765485844
CA4223490
182 E>G No ClinGen
ExAC
gnomAD
CA367224955
rs1359298655
182 E>K No ClinGen
gnomAD
CA367224994
rs1294223176
185 R>S No ClinGen
TOPMed
CA157173975
rs995806601
186 L>F No ClinGen
Ensembl
rs1238684132
CA367225008
188 I>L No ClinGen
gnomAD
rs763237665
CA4223509
189 V>G No ClinGen
ExAC
gnomAD
rs764019505
CA4223510
191 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA367225043
rs1236799534
193 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs141932676
CA4223512
195 R>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs767601192
CA4223513
196 A>V No ClinGen
ExAC
gnomAD
rs751403525
CA157174034
198 L>F No ClinGen
Ensembl
rs761763300
CA4223515
199 I>T No ClinGen
ExAC
TOPMed
gnomAD
rs1562623291
CA367225084
200 P>R No ClinGen
Ensembl
COSM223151
rs766282996
CA4223516
200 P>S skin [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs766282996
CA4223517
200 P>T No ClinGen
ExAC
gnomAD
rs370959986
CA4223520
201 G>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4223519
rs754682652
201 G>C No ClinGen
ExAC
gnomAD
CA367225102
rs1205898814
204 S>P No ClinGen
gnomAD
CA367225116
rs1562623367
206 G>R No ClinGen
Ensembl
TCGA novel 209 Y>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA157174078
rs1011541915
211 P>L No ClinGen
TOPMed
gnomAD
rs1400034194
CA367225161
212 P>L No ClinGen
gnomAD
CA367225168
rs1286569477
213 E>D No ClinGen
gnomAD
CA367225164
rs1194155105
213 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA367225167
rs1333980084
213 E>V No ClinGen
gnomAD
CA4223524
rs746224484
214 S>T No ClinGen
ExAC
gnomAD
rs141608996
CA4223527
215 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
CA4223528
rs768953294
216 A>T No ClinGen
ExAC
gnomAD
CA367225225
rs1208061569
220 E>K No ClinGen
gnomAD
rs780356081
CA4223543
221 A>D No ClinGen
ExAC
gnomAD
TCGA novel 221 A>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1268769693
CA367225231
221 A>T No ClinGen
gnomAD
CA4223545
rs144429501
222 E>A No ClinGen
ESP
ExAC
TOPMed
CA4223547
rs367896438
225 Q>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA367225270
rs1172968854
226 D>G No ClinGen
gnomAD
rs199784906
CA4223549
227 S>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA4223550
rs773449340
227 S>N No ClinGen
ExAC
TOPMed
gnomAD
rs760650706
CA4223551
230 P>S No ClinGen
ExAC
gnomAD
CA4223553
rs776270393
234 L>P No ClinGen
ExAC
gnomAD

No associated diseases with O95772

1 regional properties for O95772

Type Name Position InterPro Accession
domain MENTAL domain 48 - 218 IPR019498

Functions

Description
EC Number
Subcellular Localization
  • Late endosome membrane ; Multi-pass membrane protein
  • Localizes to contact sites between the endoplasmic reticulum and late endosomes: associates with the endoplasmic reticulum membrane via interaction with VAPA, VAPB or MOSPD2
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

9 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
endoplasmic reticulum-endosome membrane contact site A contact site between the endoplasmic reticulum membrane and the endosome membrane.
endosome A vacuole to which materials ingested by endocytosis are delivered.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
intracellular membrane-bounded organelle Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
late endosome membrane The lipid bilayer surrounding a late endosome.
lysosomal membrane The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
organelle membrane contact site A zone of apposition between the membranes of an organelle with another membrane, either another membrane of the same organelle, a membrane of another organelle, or the plasma membrane. Membrane contact sites (MCSs) are structured by bridging complexes. They are specialized for communication, including the efficient traffic of small molecules such as Ca2+ ions and lipids, as well as enzyme-substrate interactions.

2 GO annotations of molecular function

Name Definition
cholesterol binding Binding to cholesterol (cholest-5-en-3-beta-ol); the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
protein homodimerization activity Binding to an identical protein to form a homodimer.

2 GO annotations of biological process

Name Definition
cholesterol transport The directed movement of cholesterol, cholest-5-en-3-beta-ol, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
vesicle tethering to endoplasmic reticulum The initial, indirect interaction between a transport vesicle membrane and the membrane of the endoplasmic reticulum. This interaction is mediated by tethering factors (or complexes), which interact with both membranes. Interaction can occur via direct binding to membrane phospholipids or membrane proteins, or via binding to vesicle coat proteins. This process is distinct from and prior fusion.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q14849 STARD3 StAR-related lipid transfer protein 3 Homo sapiens (Human) PR
Q61542 Stard3 StAR-related lipid transfer protein 3 Mus musculus (Mouse) PR
Q9DCI3 Stard3nl STARD3 N-terminal-like protein Mus musculus (Mouse) PR
O17883 strl-1 Steroidogenic acute regulatory-like protein 1 Caenorhabditis elegans PR
10 20 30 40 50 60
MNHLPEDMEN ALTGSQSSHA SLRNIHSINP TQLMARIESY EGREKKGISD VRRTFCLFVT
70 80 90 100 110 120
FDLLFVTLLW IIELNVNGGI ENTLEKEVMQ YDYYSSYFDI FLLAVFRFKV LILAYAVCRL
130 140 150 160 170 180
RHWWAIALTT AVTSAFLLAK VILSKLFSQG AFGYVLPIIS FILAWIETWF LDFKVLPQEA
190 200 210 220 230
EEENRLLIVQ DASERAALIP GGLSDGQFYS PPESEAGSEE AEEKQDSEKP LLEL